BackNeurogene Overview

Neurogene Net Tangible Assets

Neurogene's net tangible assets is $240M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$237.78M
↓ 18.51% YoYΔ $-54.01M vs prior year quarter

Peer average / median

Loading

Neurogene Net Tangible Assets History

Loading

Neurogene vs. peers: Net Tangible Assets Comparison

Loading

Neurogene Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Neurogene (NGNE) FAQ

As of the most recent data (March 2026), NGNE shows a net tangible assets of $240M. That compares with $290M in the prior-year period — down 18.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NGNE's net tangible assets is now $240M (was $290M) — a 18.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Neurogene is outperforming or lagging.

Tracking NGNE's net tangible assets over time shows whether Neurogene is scaling, shrinking, or reshaping that part of the business. The current reading is $240M That compares with $290M in the prior-year period — down 18.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Neurogene's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $240M) with ownership activity and broader fundamentals.

Neurogene's net tangible assets is $240M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.